Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia : An Open-Label, Single-Arm, Phase 2 Study.
Latest Information Update: 05 Jan 2023
At a glance
- Drugs Camrelizumab (Primary) ; Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
Most Recent Events
- 21 Apr 2020 New trial record